The Cost of Being Ill

By Chuck Dinerstein, MD, MBA — Jan 19, 2022
As you enter those “golden” years, what does it cost you, in out-of-pocket costs, to be chronically ill? 66% of seniors have two or more chronic conditions; 16% have six or more. When discussing the cost of being ill financially, we are not talking about “chump change,” especially for those on a fixed income.

As you enter those “golden” years, what does it cost you, in out-of-pocket costs, to be chronically ill? 66% of seniors have two or more chronic conditions; 16% have six or more. When discussing the cost of being ill financially, we are not talking about “chump change,” especially for those on a fixed income.

Will 2 Marijuana Chemicals Be Able to Stop COVID?

By Josh Bloom — Jan 19, 2022
Given the proliferation of claims about the health benefits of marijuana – especially following its decriminalization – it should come as no surprise that cannabis-based chemicals are being evaluated as potential COVID therapies. Two of them, CBGA and CBDA, have been found to bind to the infamous viral spikes and inhibit the replication of COVID. Do these drugs have what it takes to make a useful drug? Read on.

Given the proliferation of claims about the health benefits of marijuana – especially following its decriminalization – it should come as no surprise that cannabis-based chemicals are being evaluated as potential COVID therapies. Two of them, CBGA and CBDA, have been found to bind to the infamous viral spikes and inhibit the replication of COVID. Do these drugs have what it takes to make a useful drug? Read on.

Popular Science Goes Down the Anti-Glyphosate Rabbit Hole

By Cameron English — Jan 18, 2022
Popular Science has joined the ranks of mainstream outlets that shill pesticide propaganda. Last week, the magazine published a story about glyphosate so atrocious that it could have been written by an activist at the Environmental Working Group.

Popular Science has joined the ranks of mainstream outlets that shill pesticide propaganda. Last week, the magazine published a story about glyphosate so atrocious that it could have been written by an activist at the Environmental Working Group.

Every Picture Tells a Story: COVID Variants of Concern

By Chuck Dinerstein, MD, MBA — Jan 18, 2022
Sometimes a picture or, in what follows, a video is worth so many words. Let’s consider the COVID variants; how could there possibly be so many so quickly. The answer, of course, lies in the work of Darwin.

Sometimes a picture or, in what follows, a video is worth so many words. Let’s consider the COVID variants; how could there possibly be so many so quickly. The answer, of course, lies in the work of Darwin.

Paxlovid vs. Molnupiravir: Patients Pick the Winner - And It's Not Close

By Josh Bloom — Jan 17, 2022
Patients and their doctors have voted with their scripts. Overwhelmingly, they are choosing Pfizer's Paxlovid and rejecting Merck's molnupiravir. So much so that when Paxlovid is unavailable (which is most of the time) many don't even bother to try the other option. Surprising?

Patients and their doctors have voted with their scripts. Overwhelmingly, they are choosing Pfizer's Paxlovid and rejecting Merck's molnupiravir. So much so that when Paxlovid is unavailable (which is most of the time) many don't even bother to try the other option. Surprising?

The Supremes Speak Out on COVID VAX in the Workplace

Four months after President Biden announced his innovative plan to compel vaccination, the U.S. Supreme Court has ruled on its validity. Biden’s plan had three parts; the Fifth Circuit Court struck them all down.

Four months after President Biden announced his innovative plan to compel vaccination, the U.S. Supreme Court has ruled on its validity. Biden’s plan had three parts; the Fifth Circuit Court struck them all down.

Continuity of Care

By Chuck Dinerstein, MD, MBA — Jan 17, 2022
Even before the time of COVID, urgent care centers (those in the trade call them docs in a box) were the go-to alternative to a long Emergency Department wait or having to see your primary care physician (PCP in the jargon) during your work hours, or in a week or so. I get it; your time is just as valuable as mine. But I wonder if something is lost in patients treating physicians as commodities and physicians treating patients as consumers. A new study looks at how the length of time seeing the same doctor influences your care.

Even before the time of COVID, urgent care centers (those in the trade call them docs in a box) were the go-to alternative to a long Emergency Department wait or having to see your primary care physician (PCP in the jargon) during your work hours, or in a week or so. I get it; your time is just as valuable as mine. But I wonder if something is lost in patients treating physicians as commodities and physicians treating patients as consumers. A new study looks at how the length of time seeing the same doctor influences your care.

Being Vaccinated: What Does It Really Mean to You and Me?

By Chuck Dinerstein, MD, MBA — Jan 14, 2022
This is another retrospective observational study, this one from England looking at the transmission of COVID-19 in both its alpha and delta variants to other adults. It helped me refine how I think about vaccines, let me share the findings and my thoughts.

This is another retrospective observational study, this one from England looking at the transmission of COVID-19 in both its alpha and delta variants to other adults. It helped me refine how I think about vaccines, let me share the findings and my thoughts.

What's Wrong with USDA's 'Bioengineered' Label? NBC Botches the Story

By Cameron English — Jan 14, 2022
The USDA's "bioengineered" (GMO) food label is expensive and pointless, facts widely disseminated by the science community. The media has been critical of the new labeling regulations as well, though for the wrong reasons. Here's a textbook example from NBC News.

The USDA's "bioengineered" (GMO) food label is expensive and pointless, facts widely disseminated by the science community. The media has been critical of the new labeling regulations as well, though for the wrong reasons. Here's a textbook example from NBC News.

'Secondhand Vaping' Risks Don't Justify Public E-cigarette Restrictions

By Cameron English — Jan 13, 2022
A new study suggests that e-cigarette users, known also as vapers, may harm the respiratory health of those around them via "secondhand vaping." Before we draw any conclusions, the paper has some important limitations that restrict its relevance to the real world.

A new study suggests that e-cigarette users, known also as vapers, may harm the respiratory health of those around them via "secondhand vaping." Before we draw any conclusions, the paper has some important limitations that restrict its relevance to the real world.